| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Mar, 2025 | Mar, 2025 |
| Sales | 693,400 | 320,670 | 0 | 0 | 0 |
| Sales Growth | +116.23% | unch | unch | unch | unch |
| Net Income | -705,810 | -289,810 | 0 | 0 | 0 |
| Net Income Growth | -143.54% | unch | unch | unch | unch |
Tempus Ai Cl A (TEM)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
47.83 -4.14 (-7.97%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 47.10 -0.73 (-1.53%) 19:58 ET
for Fri, Mar 28th, 2025
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Fiscal Year End Date: 12/31